Journal Article DZNE-2020-07163

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
[The economic and social burden of dementia diseases in Germany-A meta-analysis].

 ;  ;

2019
Springer Heidelberg

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 62(8), 981-992 () [10.1007/s00103-019-02985-z]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Currently, there are 1.7 million people living with dementia (PwD) in Germany. This number is expected to double within the next decades. Estimates of the total societal economic burden of dementia are currently missing.The aim was to estimate the current and future total cost and excess cost of dementia from a public payer and societal perspective.Studies demonstrating the healthcare resource utilization of PwD in Germany were identified. Utilization data were aggregated using the sample size of different studies as a weight. Annual per capita costs of PwD and excess cost of dementia were calculated using standardized unit costs. Current and future costs were calculated based on published prevalence and population forecasts.PwD living at home had lower costs from a payer perspective compared to those who are institutionalized, but higher total societal cost due to the higher informal care time. The total cost for PwD from a payer perspective was 34 billion € in 2016. These costs could reach 90 billion € by 2060. The excess cost of dementia was 18 billion € in 2016 and is estimated to become 49 billion € by 2060 from a payer perspective, representing 54% of the total cost of PwD and up to 15% of the total costs associated with the elderly population. The total societal cost was 73 billion € in 2016 and is estimated to become 194 billion € by 2060. The excess cost of dementia was 54 billion € in 2016 and is estimated to become 145 billion € by 2060, representing 74% of the total societal cost of PwD and 36% of the total societal cost of the elderly.Dementia diseases represent a tremendous social and economic burden. Without a cure, supporting caregivers and implementing interventions that delay the functional and cognitive decline will be crucial to relieving the increasing costs.

Keyword(s): Aged (MeSH) ; Aged, 80 and over (MeSH) ; Aging (MeSH) ; Caregivers: economics (MeSH) ; Caregivers: statistics & numerical data (MeSH) ; Cost of Illness (MeSH) ; Dementia: economics (MeSH) ; Dementia: psychology (MeSH) ; Germany (MeSH) ; Health Care Costs: statistics & numerical data (MeSH) ; Humans (MeSH) ; Patient Acceptance of Health Care (MeSH) ; Resource Allocation (MeSH)

Classification:

Contributing Institute(s):
  1. Biomarkers of Dementia in the General Population (AG Grabe)
  2. Translational Health Care Research (AG Hoffmann)
Research Program(s):
  1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2019
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; IF < 5 ; JCR ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > ROS DZNE > ROS DZNE-AG Hoffmann
Institute Collections > ROS DZNE > ROS DZNE-AG Grabe
Full Text Collection
Public records
Publications Database

 Record created 2020-02-18, last modified 2023-09-15


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)